BGB-3111-206

Completed

Study to Evaluate Efficacy and Safety of BGB-3111 in Participants With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Beigene Study ID info

BGB-3111-206

ClinicalTrials.gov ID info

Clinical Drug Trials ID info

CTR20160888

Study Overview

Sex: All

Age: 18 Years to 75 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years to 75 Years (Adult, Older Adult)

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan

You will be redirected to

Click the link above to continue or CANCEL